This report summarizes the results of the pilot study conducted by HDA, working with Ernst & Young LLP (EY) and HDA’s Traceability Pilots Work Group. The pilot study evaluated nine real-life scenarios or methods that could theoretically be employed to help meet the 2019 saleable returns requirements of the Drug Supply Chain Security Act (DSCSA). Learn about the two scenarios recommended by the work group to help pharmaceutical manufacturers and wholesale distributors comply with the DSCSA requirements.